Accessibility Menu

Septerna

(NASDAQ) SEPN

Current Price$34.03
Market Cap$1.53B
Since IPO (2024)+62%
5 YearN/A
1 Year+198%
1 Month+14%

Septerna Financials at a Glance

Market Cap

$1.53B

Revenue (TTM)

$72.26M

Net Income (TTM)

-$36.04M

EPS (TTM)

-$0.82

P/E Ratio

-41.62

Dividend

$0.00

Beta (Volatility)

1.30 (Average)

Price

$34.03

Volume

475,806.178

Open

$34.68

Previous Close

$34.00

Daily Range

$33.25 - $34.85

52-Week Range

$10.62 - $37.99

Estimated Earnings Date

Aug 10, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Septerna

Industry

Pharmaceuticals

Employees

130

CEO

Jeffrey T. Finer, MD, PhD

Headquarters

South San Francisco, CA 94080, US

SEPN Financials

Key Financial Metrics (TTM)

Gross Margin

99.42%

Operating Margin

-77.07%

Net Income Margin

-49.88%

Return on Equity

-9.44%

Return on Capital

-19.92%

Return on Assets

-6.33%

Earnings Yield

-2.40%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.53B

Shares Outstanding

45.08M

Volume

475.81K

Avg. Volume

382.02K

Financials (TTM)

Gross Profit

$71.83M

Operating Income

-$55.69M

EBITDA

-$52.12M

Operating Cash Flow

$107.90M

Capital Expenditure

-$968.00K

Free Cash Flow

$106.93M

Cash & ST Invst.

$347.40M

Total Debt

$23.09M

Septerna Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$26.52M

+12011.0%

Gross Profit

$26.10M

+11818.7%

Gross Margin

98.41%

N/A

Market Cap

$1.53B

N/A

Market Cap/Employee

$11.79M

N/A

Employees

130

N/A

Net Income

-$8.64M

+59.8%

EBITDA

-$7.88M

+62.6%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$347.40M

+3.4%

Total Debt

$23.09M

-7.7%

Accounts Receivable

$14.29M

+977.7%

Inventory

$0.00

N/A

Long Term Debt

$20.78M

-10.0%

Short Term Debt

$2.31M

+19.2%

Return on Assets

-6.33%

N/A

Return on Invested Capital

-11.33%

N/A

Free Cash Flow

-$26.47M

-11.5%

Operating Cash Flow

-$25.63M

-9.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BCAXBicara Therapeutics Inc. Common Stock
$29.00+0.31%
FTREFortrea Holdings Inc.
$17.28-1.71%
MRVIMaravai LifeSciences Holdings, Inc.
$6.04-1.79%
EYPTEyePoint Pharmaceuticals, Inc.
$13.98+5.95%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.30-0.15%
CLROClearOne
$6.48+1.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$73.35-0.05%
ONDSOndas
$7.41-0.06%

Questions About SEPN

What is the current price of Septerna?

Septerna is trading at $34.00 per share.

What is the 52-week range for Septerna?

Over the past 52 weeks, Septerna has traded between $10.62 and $37.99.

How much debt does Septerna have?

As of the most recent reporting period, Septerna reported total debt of $23.09M.

How much cash does Septerna have on hand?

Septerna reported $71.61M in cash and cash equivalents in its most recent financial results.

What is Septerna’s dividend yield?

Septerna does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.